ArticleBlood advances2021
Oran B, de Lima M, Garcia-Manero G, et al. A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients. Blood Adv. 2020;4(21):5580-5588.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.